MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
Huang, Feng-Ting
MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. [electronic resource] - Digestive diseases and sciences 04 2017 - 944-957 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1573-2568
10.1007/s10620-017-4472-7 doi
Aged
Animals
Biomarkers, Tumor--genetics
Carcinoma, Pancreatic Ductal--genetics
Cell Line, Tumor
Disease Progression
Female
Humans
MAP Kinase Kinase Kinases--antagonists & inhibitors
MAP Kinase Signaling System--physiology
Male
Mice, Inbred BALB C
Mice, Nude
MicroRNAs--genetics
Middle Aged
NF-kappa B--genetics
Pancreatic Neoplasms--genetics
Xenograft Model Antitumor Assays--methods
MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. [electronic resource] - Digestive diseases and sciences 04 2017 - 944-957 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1573-2568
10.1007/s10620-017-4472-7 doi
Aged
Animals
Biomarkers, Tumor--genetics
Carcinoma, Pancreatic Ductal--genetics
Cell Line, Tumor
Disease Progression
Female
Humans
MAP Kinase Kinase Kinases--antagonists & inhibitors
MAP Kinase Signaling System--physiology
Male
Mice, Inbred BALB C
Mice, Nude
MicroRNAs--genetics
Middle Aged
NF-kappa B--genetics
Pancreatic Neoplasms--genetics
Xenograft Model Antitumor Assays--methods